About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Side effect(s) of Bictegravir, Emtricitabine, and Tenofovir Alafenamide

Read the side effects of Bictegravir, Emtricitabine, and Tenofovir Alafenamide as described in the medical literature. In case of any doubt consult your doctor or pharmacist.

Common: Diarrhea, nausea, headache

Gastrointestinal: Loss of appetite, stomach discomfort

Respiratory: Difficulty in breathing

Nervous system: Inability to sleep, fatigue, abnormal dreams, dizziness

Others: Kidney impairment, decreased phosphorous levels in the blood, abnormal level of liver enzymes and alteration in neutrophil counts.

Other Precautions :  Do not alter the dose or stop treatment without consulting the physician.
Take exactly as directed and at the same time every day.
Refill the medications before running short, as discontinuation even for short periods results in viral resistance which becomes difficult to treat.
Medications should not be shared with other patients without physician approval even if they have a similar infection.

Drug Name : Bictegravir, Emtricitabine, and Tenofovir Alafenamide

Bictegravir, Emtricitabine, and Tenofovir Alafenamide generic Bictegravir, emtricitabine, and tenofovir alafenamide is a three-drug combination where bictegrair is an HIV-1 integrase strand transfer inhibitor, and emtricitabine and tenofovir alafenamide are HIV -1 nucleoside analog reverse transcriptase inhibitors prescribed to treat HIV infections in adults. The drug combination can be used in patients- Who has not been previously treated with antiretroviral therapy To replace current antiretroviral therapy for those who are virologically suppressed after taking antiretroviral regimen for at least three months; these patients must not have had any failed treatment nor any known substitutions associated with resistance to the individual components.
More Info about Bictegravir, Emtricitabine, and Tenofovir Alafenamide

Advertisement



Advertisement
Recommended Reading
Advertisement
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close